✦ LIBER ✦

Surrogate end points in cardiovascular disease trials

✍ Scribed by Thomas R. Fleming

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate End Points in Secondary Analys

✍ Kevin A. Buhr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Surrogate End Points Cloud DES Trials

✍ JASON KAHN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Surrogate end points in heart failure tr

✍ Mihai Gheorghiade; Kirkwood F. Adams Jr; Wendy A. Gattis; John R. Teerlink; Cesa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 70 KB

On the use of surrogate end points in ra

✍ C. B. Begg; D. H. Y. Leung 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Are Surrogate End Points in Drug-Eluting

✍ Pierfrancesco Agostoni; Giuseppe G.L. Biondi-Zoccai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Validation of surrogate end points in mu

✍ Tomasz Burzykowski; Geert Molenberghs; Marc Buyse; Helena Geys; Didier Renard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB